glp 1 inventor She's not your everyday scientist 🥼🧪 Meet our Chief Scientific Advisor, Lotte Bjerre Knudsen., A scientist at Novo Nordisk since 1989, she is one of the co-inventors of the first long-acting GLP-1 Richard DiMarchi, pioneering IU peptide

Furthermore, it improves cardiovascular function, increases sleep quality, and manages symptoms of dementia [1, 2, 3]

During this 30-day period, keep your injection away from direct sunlight, heat sources, and extreme temperature swings

Key Characteristics of Cagrilintide (10mg) Long-acting amylin analogue: A modified form of amylin designed to remain active longer than the native hormone in research settings

No regulator anywhere in the world has approved it for any clinical indication

Photo by Innerbody Research Around 30-50% of American adults dont get enough sleep.1 The consequences of this insufficiency can be steep, as without a regular 7-8 hours rest per night, a person can find themselves at risk for depression, decreased cognitive function, and an increased risk of cardiovascular and endocrine dysfunction.2 For the many millions of people with sleep deficiency, a peptide called DSIP could be a solution, although some researchers might disagree